Study

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease. – Cost Effective Supplements

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/19838862


Conclusion of this study

This phase II study provides preliminary evidence of a possible therapeutic effect of saffron extract in the treatment of patients with mild-to-moderate Alzheimer's disease. This trial is registered with the Iranian Clinical Trials Registry (IRCT138711051556N1).


Supplements analyzed in this study

Saffron

Health conditions analyzed in this study

Alzheimer's Disease


Slightly Positive
Saffron


Functions related to this study

Mental health


Slightly Positive
Saffron


Body systems related to this study


Nervous System
Scroll to top